Agilent Technologies Inc. Completes Acquisition of BioSystem Development Business, Including AssayMAP Microchromatography Platform for Automated Analytical Solutions for Pharma
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of the BioSystem Development business. BioSystem Development is a privately held company that develops and manufactures the AssayMAP Microchromatography platform to meet the analytical needs of the life sciences industry.